Infection by Nocardia brasiliensis is usually localized to the skin but can rarely spread to the lung, brain, or multiple sites particularly in the immunocompromised hosts. Moreover, primary systemic involvement without cutaneous disease is an extremely rare case. In the current study, we present a case of primary pulmonary nocardiosis caused by a multi-drug resistant N brasiliensis along with a review of the cases reported from India.
Introduction
Pulmonary infections, despite being the leading infectious cause of hospitalization and death worldwide, are often misdiagnosed, mistreated, and underestimated. Diagnosis is usually made by clinical features (history and physical examination) and chest imaging. Establishing a microbial etiology is necessary where unusual or drug-resistant pathogens are suspected in patients with immunocompromised states or in patients who are not responding to empirical antimicrobial agents. Culture and susceptibility data enable pathogen-directed therapy and show trends in antimicrobial resistance. [1] Nocardiosis is an uncommon pulmonary infection and is only kept as differential in cases of nonresolving pneumonia in patients with compromised cell-mediated innate immunity. The majority of cases of pulmonary nocardiosis are caused by Nocardia asteroides and the drug of choice is cotrimoxazole. [2, 3] We recently had the opportunity of observing a patient with acute fatal pulmonary nocardiosis caused by a multi-drug resistant N brasiliensis.
Case Description
A 65-year-old gentleman was admitted with high-grade fever, productive cough, and rapidly progressive dyspnea for 7 days in a medical intensive care unit.
Six years ago the patient was diagnosed with chronic obstructive pulmonary disease (COPD) and pulmonary tuberculosis (PTB) and had received antituberculosis treatment for 6 months. Currently, he was on inhaled corticosteroids and bronchodilators for COPD. He had no history of diabetes mellitus (DM) and use of systemic steroids or chronic alcohol consumption. He was an ex-smoker and was a farmer by occupation.
On admission, the patient had tachypnea with respiratory rate 30 breaths per min and oxygen saturation of 88% while breathing in ambient air. Lung auscultation revealed bilateral diffuse crackles and rhonchi. A provisional diagnosis of acute exacerbation of COPD with community-acquired pneumonia or suspected PTB relapse was made and the patient was started on intravenous antibiotics (ceftriaxone, amikacin, and ofloxacin), high flow oxygen, nebulization with bronchodilators, and intravenous hydrocortisone.
Laboratory investigations showed leukocytosis (11.4 × 10 9 /l), high erythrocyte sedimentation rate (80 mm/h), and normal liver and renal function tests. A chest X-ray (CXR) showed diffuse bilateral airspace opacities with right upper lobe fibrosis. Blood glucose levels were normal and an HIV serology was nonreactive.
Sputum examination showed gram-positive beaded, branching, thin filamentous bacteria resembling Nocardia spp. The bacterium was acid-fast on modified (1%) Ziehl-Neelsen (ZN) stain [ Figure 1 ]. Sputum specimen was cultured on nutrient agar and blood agar and after 72 h of incubation white dry colonies with rough surface were seen [ Figure 2 a and b]. Gram and ZN staining of these colonies revealed bacteria resembling Nocardia spp. The bacterium was identified as N brasiliensis by standard biochemical tests. Antibiotic susceptibility testing by disc diffusion method showed that the isolate was susceptible to amikacin, ceftriaxone, doxycycline, chlorpheniramine, and imipenem but resistant to cotrimoxazole and aztreonam [ Figure 3 ].
Initially, cotrimoxazole was started after sputum microscopy examination but later it was changed to imipenem after antimicrobial susceptibility results. Despite this, the patient developed rapidly progressive respiratory failure and septic shock and could not be revived.
Discussion
Pulmonary nocardiosis is typically regarded as an uncommon opportunistic infection which causes high mortality. Dysfunction of cell-mediated immunity is a major predisposing factor and patients with uncontrolled DM, HIV, malignancy, organ or stem cell transplant, alcoholism, and long-term use of immunosuppressive agents (e.g. steroids) are particularly at risk. [2, 4, 5] Pulmonary nocardiosis usually has a subacute (weeks to months) or chronic (months to years) presentation and may mimic tuberculosis or lung cancer. Acute pulmonary infection (days) is usually fulminant and is commoner in immuno-suppressed individuals. Clinical features are nonspecific and a constellation of fever, cough, dyspnea, chest pain, anorexia, or weight loss. As pulmonary nocardiosis is a great mimicker, it may have a plethora of radiological findings; common being consolidation, nodules, or lung mass; solitary or multiple; and with or without breakdown or cavitation. For diagnosis, a strong clinical suspicion is needed, and it requires isolation and identification of Nocardia from a clinical specimen that is, sputum, broncho-alveolar lavage (BAL), fine needle aspiration, or biopsy. [2, 4, 5] N asteroides accounts for up to 90% of the reported cases. N brasiliensis is usually limited to cutaneous and lymphocutaneous disease but can rarely spread to produce pulmonary or disseminated disease in immunosuppressed hosts. [2, 4, 5] A PubMed/MEDLINE search of literature tracked a total of eight adult Indian patients with a diagnosis of pulmonary nocardiosis by N brasiliensis [ Table 1 ]. [6] [7] [8] [9] [10] [11] [12] Age and sex distribution (mean age 51.66 years; median age 45 years; male preponderance); underlying conditions (common being chronic lung disease and chronic steroid use); clinico-radiological features; and mortality (more with acute presentation and cotrimoxazole resistant cases) are similar to overall pulmonary nocardiosis cases. The involvement of the lung is usually thought to occur after transcutaneous inoculation by N brasiliensis; however, in the reviewed cases, only two out of nine had primary cutaneous nocardiosis.
In conclusion, inhalation may be the primary route of infection by N brasiliensis. Primary care physicians should have awareness of pulmonary nocardiosis as correct and efficient diagnosis is quite challenging. Moreover, cotrimoxazole resistant cases have poor outcomes.
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